IN medicine, precision is everything. A single misinterpretation, a missed interaction, or a delay in treatment can have real consequences for patient outcomes. Yet, in Jamaica today, one of the most critical elements of patient care, the prescription, often relies on handwritten notes that are vulnerable to error.

For decades, handwritten prescriptions have been accepted as standard practice. However, what has long been normalised does not necessarily equate to what is safest. Illegible handwriting remains a persistent issue, not just locally but globally. Pharmacists are frequently placed in the position of interpreting unclear instructions, sometimes having to call physicians for clarification or make judgement calls under pressure. Each of these steps introduces avoidable risk.

Beyond legibility, paper prescriptions lack structure. There is no automatic check for drug interactions, no standardised format, and no built in safeguards to prevent duplication or misuse. In a healthcare environment where patients may see multiple providers and use multiple pharmacies, this fragmentation increases the likelihood of medication errors.

Electronic prescription systems directly address these gaps. By digitising the prescribing process, medications are clearly documented, standardised, and transmitted directly to the pharmacy. There is no ambiguity in drug name, dosage, or instructions. More importantly, these systems can incorporate clinical decision support, flagging potential drug interactions, allergies, or contraindications in real time.

The benefits extend beyond the individual patient. Electronic prescriptions create a traceable and auditable record of care. This is particularly important in addressing issues such as prescription fraud, duplication, and misuse of controlled medications. With a secure digital trail, accountability is strengthened across the entire healthcare system, from prescriber to dispenser.

It is also important to acknowledge that Jamaica has already begun informally transitioning toward digital communication. Prescriptions are often shared via messaging platforms or photos. While this reflects a willingness to adapt, it introduces new risks around data security, authenticity, and standardisation. The solution is not to resist digitisation, but to formalise it through secure, purpose built systems designed for healthcare.

The question is no longer whether Jamaica should move toward electronic prescriptions, but how quickly and effectively it can do so. The infrastructure exists. The need is clear. Most importantly, the potential to improve patient safety is significant.

Health-care systems evolve when they align with one fundamental principle, reducing preventable harm. Transitioning from paper to electronic prescriptions is not simply a technological upgrade, it is a necessary step toward safer, more reliable care for every Jamaican.

Dr Ché Bowen is CEO, MDLink, Flowscript and digital health consultant. E-mail: drchebowen@themdlink.com.

Dr CHE BOWEN.